Glioblastoma-enriched glycosphingolipids modulate the function of human iNKT cells

Area of Science:

• Immunology
• Neuro-oncology
• Metabolomics

Background:

• Glioblastoma (GBM) requires novel therapies, necessitating understanding of its immune regulation.
• Invariant natural killer T (iNKT) cells, known tumor immunity regulators, are hypothesized to be influenced by GBM's lipid-rich environment.
• GBM cells' unique metabolism may lead to lipid production that promotes disease immunosuppression.

Purpose of the Study:

• To investigate the role of GBM-enriched lipids in modulating iNKT cell function.
• To determine if specific lipids produced by GBM stem-like cells (GSCs) affect iNKT cell activity.
• To explore potential therapeutic targets within GBM lipid metabolism.

Main Methods:

• Lipid profiling of human GBM stem-like cell lines, low-grade glioma lines, and normal astrocytes using liquid-chromatography mass spectrometry.
• Testing GSC-enriched lipids for iNKT cell antigenicity and activation using human iNKT cell lines and peripheral blood mononuclear cells (PBMCs) from healthy donors and GBM patients.
• Assessing the impact of targeting the sulfatide synthetic pathway in GSCs on iNKT cell activation.

Main Results:

• Glioblastoma stem-like cells uniquely enriched multiple lipid species, particularly sulfatides.
• Sulfatides were recognized and activated iNKT cells in a CD1d-dependent manner.
• Targeting sulfatide synthesis altered iNKT cell activation, while lyso-sulfatide inhibited iNKT cell activation and suppressed responses to a known antigen.

Conclusions:

• Glioblastoma stem-like cell-enriched glycosphingolipids, like sulfatides, modulate iNKT cell function.
• This modulation may contribute to GBM's immunosuppressive tumor microenvironment.
• Sulfatide production represents a potential therapeutic target for glioblastoma treatment.